21: Cipla: What a Cambridge start-up has to do with Yusuf Hamied

… and how that can shape global pharma

The first-time developments in global pharma caught my attention was in 2014 when I heard Prof. Ken Shadlen’s passionate lecture at the LSE. I was then a student enrolled in the fascinating postgradu…